Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brauer PM, Zheng Y, Evans MD, Dominguez-Brauer C, Peehl DM, Tyner AL. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin. PLoS One. 2011;6(3):e14789. https://doi.org/10.1371/journal.pone.0014789.
Castro NE, Lange CA. Breast tumor kinase and extracellular-signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Breast Cancer Res. 2010;12(4):R60. https://doi.org/10.1186/bcr2622.
Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 2008;68(1):152–61. https://doi.org/10.1158/0008-5472.CAN-07-2126.
Goel RK, Lukong KE. Tracing the footprints of the breast cancer oncogene BRK – past till present. Biochim Biophys Acta. 2015;1856:39–54. https://doi.org/10.1016/j.bbcan.2015.05.001.
Hanahan D, Weinberg RA. Hallmarks of cancer. Cell. 2000;100:57–70.
Haines RJ, Beard Jr RS, Eitner RA, Chen L, Wu MH. TNFα/IFNγ mediated intestinal epithelial barrier dysfunction is attenuated by microRNA-93 downregulation of PTK6 in mouse colonic epithelial cells. PLoS One. 2016;11:1–18. https://doi.org/10.1371/journal.pone.0154351.
Harvey AJ, Pennington C, Porter S, Burmi RS, Edwards DR, Court W, et al. Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage. Am J Pathol. 2009;175(3):1226–34. https://doi.org/10.2353/ajpath.2009.080811.
Harvey AJ, Burmi RS. Future therapeutic strategies: implications for Brk targeting. In: Gundez E, Gundez M, editors. Breast cancer: current and alternative therapeutic modalities. InTech; 2011. 413–35.
Hussain HA, Harvey AJ. Evolution of breast cancer therapeutics: breast tumour kinase’s role in breast cancer and hope for breast tumour kinase targeted therapy. World J Clin Oncol. 2014;5(3):299–310. https://doi.org/10.5306/wjco.v5.i3.299.
Irie HY, Shrestha Y, Selfors LM, Frye F, Iida N, Wang Z, et al. PTK6 regulates IGF-1-induced anchorage-independent survival. PLoS One. 2010;5(7):e11729. https://doi.org/10.1371/journal.pone.0011729.
Kim HI and Lee S-T. Oncogenic Functions of PTK6 Are Enhanced by Its Targeting to Plasma Membrane But Abolished by Its Targeting to Nucleus. J Biochem. 2009;146(1):133-9. doi: 10.1093/jb/mvp050.
Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem. 2005;280(46):38639–47. https://doi.org/10.1074/jbc.M505802200.
Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, Gusterson BA and Crompton MR. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene. 1994;9(8):2383–2390.
Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CJ. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 2007;67(9):4199–209. https://doi.org/10.1158/0008-5472.CAN-06-3409.
Park SH, Ito K, Olcott W, Katsyv I, Halstead-Nussloch G, Irie HY. PTK6 inhibition promotes apoptosis of lapatinib-resistant HER2+ breast cancer cells by inducing Bim. Breast Cancer Res. 2015;17:86. https://doi.org/10.1186/s13058-015-0594-z.
Peng M, Emmadi R, Wang Z, Wiley EL, Gann PH, Khan SA, Banerji N, McDonald W, Asztalos S, Pham TN, Tonetti DA, Tyner AL. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma memebrane in breast tumors. Oncotarget. 2014;15(5):6038–48. https://doi.org/10.18632/oncotarget.2153.
Peng M, Ball-Kell SM, Tyner AL. Protein tyrosine kinase 6 promotes ErbB2-induced mammary gland tumorigeneses in the mouse. Cell Death Dis. 2015;6:e1848. https://doi.org/10.1038/cddis.2015.210.
Pires IM, Blokland NJ, Broos AW, Poujade FA, Senra JM, Eccles SA, Span PN, Harvey AJ, Hammond EM. Hif-1α-independent hypoxia-induced rapid PTK6 stabilzation is associated with increased motility and invasion. Cancer Biol Ther. 2014;15(10):1350–7. https://doi.org/10.4161/cbt.29822.
Zhang P, Ostrander JH, Faivre EJ, Olsen A, Fitzimmons D, Lange CA. Regulated association of protein kinase B/Akt with breast tumor kinase. J Biol Chem. 2005;280(3):1982–91. https://doi.org/10.1074/jbc.M412038200.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Harvey, A. (2018). Protein Tyrosine Kinase-6 (PTK6). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_305
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_305
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences